Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 8:10 pm Unchanged | 13G | PANBELA THERAPEUTICS INC C PBLA | Lind Global Fund II LP | 0 0% | 0 (Unchanged) | View |
| 2024-02-13 8:10 pm Sale | 13G | PALISADE BIO INC PALI | Lind Global Fund II LP | 158,355 1.7% | -584,958 (-78.70%) | View |
| 2024-02-13 8:09 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Lind Global Fund II LP | 125,520 3.9% | 125,520 (New Position) | View |
| 2024-02-13 8:09 pm Purchase | 13G | MOBIQUITY TECHNOLOGIES INC MOBQ | Lind Global Fund II LP | 405,000 9.9% | 405,000 (New Position) | View |
| 2024-02-13 8:08 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 845,000 9.9% | 499,490 (+144.57%) | View |
| 2024-02-13 8:08 pm Purchase | 13G | INTELLIGENT BIO SOLUTIONS INC INBS | Lind Global Fund II LP | 960,000 9.9% | 574,000 (+148.70%) | View |
| 2024-02-13 8:06 pm Purchase | 13G | GSE SYS INC GVP | Lind Global Fund II LP | 300,568 9.9% | 300,568 (New Position) | View |
| 2024-02-13 8:06 pm Sale | 13G | GROM SOCIAL ENTERPRISES INC CO GROM | Lind Global Fund II LP | 0 0% | -240,088 (Position Closed) | View |
| 2024-02-13 8:05 pm Purchase | 13G | ENERGY FOCUS INC PAR $0.00 EFOI | Lind Global Fund II LP | 117,508 2.6% | 117,508 (New Position) | View |
| 2024-02-13 8:05 pm Purchase | 13G | EDIBLE GARDEN AG INC EDBL | Lind Global Fund II LP | 571,824 9.9% | 371,824 (+185.91%) | View |
| 2024-02-13 8:05 pm Sale | 13G | CEA IND INC CEAD | Lind Global Fund II LP | 415,000 4.9% | -139,899 (-25.21%) | View |
| 2024-02-13 8:04 pm Purchase | 13G | BLUE STAR FOODS CORP COM BSFC | Lind Global Fund II LP | 1,590,000 9.9% | 1,590,000 (New Position) | View |
| 2024-02-13 8:04 pm Purchase | 13G | BIO-KEY INTL INC PAR $0.00 BKYI | Lind Global Fund II LP | 46,285 4.7% | 46,285 (New Position) | View |
| 2024-02-13 8:03 pm Purchase | 13G | BIOLASE INC PAR $.001 BIOL | Lind Global Fund II LP | 9,210 0.4% | 9,210 (New Position) | View |
| 2024-02-13 8:03 pm Purchase | 13G | BONE BIOLOGICS CORP COM DE BBLG | Lind Global Fund II LP | 34,180 6% | 34,180 (New Position) | View |
| 2024-02-13 8:03 pm Purchase | 13G | GOLDEN MINERALS CO COM AUMN | Lind Global Fund II LP | 1,502,477 9.9% | 142,477 (+10.48%) | View |
| 2024-02-13 8:02 pm Sale | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Lind Global Fund II LP | 0 0% | -3,000,000 (Position Closed) | View |
| 2024-02-13 8:02 pm Purchase | 13G | AGILE THERAPEUTICS INC PAR AGRX | Lind Global Fund II LP | 44,750 1.8% | 44,750 (New Position) | View |
| 2024-02-13 8:00 pm Sale | 13G | TALPHERA, INC. TLPH | Lind Global Fund II LP | 735,296 4.2% | -367,648 (-33.33%) | View |
| 2024-02-13 7:59 pm Purchase | 13G | ABVC BIOPHARMA INC ABVC | Lind Global Fund II LP | 770,000 9.9% | 770,000 (New Position) | View |